DRREDDY Dr Reddy's Laboratories Ltd Investments/Divestments Announcement 2024 - License Agreement for Cyclophosphamide Injection RTD in the U.S. Dr. Reddys USA entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. Sales of the product for the past 12 months ended March 2024 were $51.8 million..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd